Adverse Events of PD-1, PD-L1, CTLA-4, and LAG-3 Immune Checkpoint Inhibitors: An Analysis of the FDA Adverse Events Database
Article in Antibodies (July 2024)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Antibodies (July 2024)